Petco Health & Wellness Company, Inc.

For the period ended Aug 1, 2026. Filed Sep 4, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Aug 1, 2026 · Filed Sep 4, 2026

WOOF$3.10+4.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Equity

	Common stock
	Class A (shares)	Class B-1 (shares)	Class B-2 (shares)	Amount	Additional paid-in capital	Accumulateddeficit	Accumulatedothercomprehensiveloss	Totalstockholders’equity
Balance at January 31, 2026	243,719	37,791	37,791	$282	$2,312,354	$(1,139,993)	$(8,389)	$1,164,254
Equity-based compensation expense (Note 7)	—	—	—	—	9,451	—	—	9,451
Net loss	—	—	—	—	—	(15,146)	—	(15,146)
Foreign currency translation adjustment, net of tax	—	—	—	—	—	—	(1,118)	(1,118)
Unrealized gain on derivatives (Note 5), net of tax	—	—	—	—	—	—	752	752
Losses on derivatives reclassified to income (Note 5), net of tax	—	—	—	—	—	—	37	37
Issuance of common stock, net of tax withholdings	3,634	—	—	3	(2,928)	—	—	(2,925)
Balance at May 2, 2026	247,353	37,791	37,791	$285	$2,318,877	$(1,155,139)	$(8,718)	$1,155,305
Equity-based compensation expense (Note 7)	—	—	—	—	8,599	—	—	8,599
Net income	—	—	—	—	—	38,660	—	38,660
Foreign currency translation adjustment, net of tax	—	—	—	—	—	—	3,538	3,538
Unrealized gain on derivatives (Note 5), net of tax	—	—	—	—	—	—	186	186
Gains on derivatives reclassified to income (Note 5), net of tax	—	—	—	—	—	—	(56)	(56)
Issuance of common stock, net of tax withholdings	896	—	—	1	694	—	—	695
Balance at August 1, 2026	248,249	37,791	37,791	$286	$2,328,170	$(1,116,479)	$(5,050)	$1,206,927

	Common stock
	Class A (shares)	Class B-1 (shares)	Class B-2 (shares)	Amount	Additional paid-in capital	Accumulateddeficit	Accumulatedothercomprehensive loss	Totalstockholders’equity
Balance at February 1, 2025	239,066	37,791	37,791	$277	$2,280,495	$(1,149,059)	$(18,083)	$1,113,630
Equity-based compensation expense (Note 7)	—	—	—	—	9,445	—	—	9,445
Net loss	—	—	—	—	—	(11,661)	—	(11,661)
Foreign currency translation adjustment, net of tax	—	—	—	—	—	—	32	32
Unrealized loss on derivatives (Note 5), net of tax	—	—	—	—	—	—	(2,267)	(2,267)
Gains on derivatives reclassified to income (Note 5), net of tax	—	—	—	—	—	—	(159)	(159)
Issuance of common stock, net of tax withholdings	1,765	—	—	2	(1,692)	—	—	(1,690)
Balance at May 3, 2025	240,831	37,791	37,791	$279	$2,288,248	$(1,160,720)	$(20,477)	$1,107,330
Equity-based compensation expense (Note 7)	—	—	—	—	8,807	—	—	8,807
Net income	—	—	—	—	—	13,972	—	13,972
Foreign currency translation adjustment, net of tax	—	—	—	—	—	—	7,637	7,637
Unrealized gain on derivatives (Note 5), net of tax	—	—	—	—	—	—	861	861
Gains on derivatives reclassified to income (Note 5), net of tax	—	—	—	—	—	—	(152)	(152)
Issuance of common stock, net of tax withholdings	1,233	—	—	1	647	—	—	648
Balance at August 2, 2025	242,064	37,791	37,791	$280	$2,297,702	$(1,146,748)	$(12,131)	$1,139,103

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.